Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Witting

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Thrombosis Research|May 15, 1987
Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditionsJ I Witting, T M Miller, J W Fenton
Annals of the New York Academy of Sciences|January 1, 1989
Thrombin anion-binding exosite interactions with heparin and various polyanionsJ W Fenton, J I Witting, C Pouliott, et al.
The Biochemical Journal|October 15, 1992
Hirulog-1 and -B2 thrombin specificityJ I Witting, P Bourdon, J M Maraganore, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 1, 1997
Thrombin affinity mapping of its receptor tethered ligandJ I Witting, D V Brezniak, T T Andersen, et al.
Thrombosis Research|August 15, 1991
Human alpha- and zeta-thrombin inhibition by recombinant HV1 and HV2K47 hirudinsJ I Witting, D V Brezniak, J R Hayes, et al.
Thrombosis Research|May 15, 1988
Thrombin inhibition with dipeptidyl argininalsJ I Witting, C Pouliott, J L Catalfamo, et al.
The Biochemical Journal|May 1, 1992
Thrombin-specific inhibition by and slow cleavage of hirulog-1J I Witting, P Bourdon, D V Brezniak, et al.
Biochemistry|April 10, 1990
Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retainedD V Brezniak, M S Brower, J I Witting, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
The rational design of thrombin-directed antithromboticsJ W Fenton, F Ni, J I Witting, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Thrombosis Research|May 15, 1987
Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditionsJ I Witting, T M Miller, J W Fenton
Annals of the New York Academy of Sciences|January 1, 1989
Thrombin anion-binding exosite interactions with heparin and various polyanionsJ W Fenton, J I Witting, C Pouliott, et al.
The Biochemical Journal|October 15, 1992
Hirulog-1 and -B2 thrombin specificityJ I Witting, P Bourdon, J M Maraganore, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 1, 1997
Thrombin affinity mapping of its receptor tethered ligandJ I Witting, D V Brezniak, T T Andersen, et al.
Thrombosis Research|August 15, 1991
Human alpha- and zeta-thrombin inhibition by recombinant HV1 and HV2K47 hirudinsJ I Witting, D V Brezniak, J R Hayes, et al.
Thrombosis Research|May 15, 1988
Thrombin inhibition with dipeptidyl argininalsJ I Witting, C Pouliott, J L Catalfamo, et al.
The Biochemical Journal|May 1, 1992
Thrombin-specific inhibition by and slow cleavage of hirulog-1J I Witting, P Bourdon, D V Brezniak, et al.
Biochemistry|April 10, 1990
Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retainedD V Brezniak, M S Brower, J I Witting, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
The rational design of thrombin-directed antithromboticsJ W Fenton, F Ni, J I Witting, et al.
Pageof 1